Join us for the conclusion of our 30-day deep dive into drug development regulations, a journey spanning clinical trials, biologics, biosimilars, and the evolving regulatory landscape. Reflect on the rigorous processes ensuring medication safety and efficacy, from clinical trials to post-market surveillance. As we transition into exploring cannabinoids and psychedelics, we’ll tackle their science, potential benefits, ethical challenges, and regulatory hurdles. Stay curious and engaged as we unlock the future of medicine together.